Asthma und Chronisch-obstruktive Lungenerkrankung
- 1 January 2023
- book chapter
- Published by Springer Nature
- p. 641-657
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive SummaryEuropean Respiratory Journal, 2023
- Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for people with asthmaCochrane Database of Systematic Reviews, 2021
- Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthmaCochrane Database of Systematic Reviews, 2021
- Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2021
- Mitochondrial dysfunction in lung ageing and diseaseEuropean Respiratory Review, 2020
- Dual LABA/LAMA Therapy versus LABA or LAMA Monotherapy for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis in Support of the American Thoracic Society Clinical Practice GuidelineAnnals of the American Thoracic Society, 2020
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019European Respiratory Journal, 2019
- Anti-IL5 therapies for asthmaCochrane Database of Systematic Reviews, 2017
- Development of New Therapies for Severe AsthmaAllergy, Asthma & Immunology Research, 2017
- Omalizumab for asthma in adults and childrenCochrane Database of Systematic Reviews, 2014